Endoscopic Devices - Southern Europe

  • Southern Europe
  • In Southern Europe, revenue in the Endoscopic Devices market market is projected to reach US$2.05bn in 2024.
  • The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 6.59%, leading to a market volume of US$2.82bn by 2029.
  • In a global comparison, the United States is expected to generate the highest revenue, amounting to US$10,390.00m in 2024.
  • The endoscopic devices market in Southern Europe is witnessing significant growth due to increasing surgical procedures and a rising focus on minimally invasive techniques.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market in Southern Europe is witnessing moderate growth, influenced by factors such as technological advancements, increasing prevalence of chronic diseases, and the rising demand for minimally invasive procedures among healthcare providers and patients.

Customer preferences:
Consumers in Southern Europe are increasingly favoring minimally invasive surgical options, reflecting a cultural shift towards prioritizing quicker recovery and reduced hospital stays. This preference is largely influenced by an aging population that seeks effective yet less invasive treatment alternatives. Additionally, the rise of health-conscious younger demographics has heightened awareness around preventive care, further driving demand for innovative endoscopic devices. As lifestyles evolve, patients are prioritizing procedures that offer lower risks and improved outcomes, reshaping the market landscape.

Trends in the market:
In Southern Europe, the Endoscopic Devices Market is experiencing a surge in demand for advanced minimally invasive surgical technologies, as patients increasingly seek procedures that ensure quicker recovery times and reduced hospital stays. This trend is significantly driven by an aging population that prioritizes effective yet less invasive treatment options. Additionally, health-conscious younger demographics are fueling the market with a growing emphasis on preventive care and innovative solutions. As these dynamics evolve, industry stakeholders must adapt by investing in research and development to enhance device capabilities, improving patient outcomes while navigating the competitive landscape.

Local special circumstances:
In Southern Europe, the Endoscopic Devices Market is shaped by distinct geographical and cultural factors that influence its growth. The region's diverse healthcare systems and varying levels of public and private investment in medical technology create a complex landscape for market entry. Furthermore, cultural attitudes towards health and wellness emphasize holistic and minimally invasive treatments, driving demand for advanced endoscopic solutions. Regulatory bodies are also adapting to these trends by streamlining approval processes for innovative devices, fostering a more competitive environment that encourages rapid advancements in technology and patient care.

Underlying macroeconomic factors:
The Endoscopic Devices Market in Southern Europe is significantly influenced by macroeconomic factors such as national economic stability, healthcare spending, and demographic trends. Economic growth in the region has led to increased public and private investment in medical technology, enhancing access to cutting-edge endoscopic solutions. Additionally, stringent fiscal policies aimed at improving healthcare efficiency drive demand for minimally invasive procedures, aligning with patient preferences for reduced recovery times. Furthermore, an aging population and rising incidence of chronic diseases elevate the need for advanced diagnostic and therapeutic options, propelling market expansion amidst global healthcare trends.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)